Cargando…

Scoping review protocol on the impact of antimicrobial resistance on cancer management and outcomes

INTRODUCTION: Antimicrobial resistance (AMR) is a growing global public health concern and is becoming a significant challenge in the management of patients with cancer. Due to the immunosuppressive nature of cancer treatment, infection is a common complication and the necessary high usage of antibi...

Descripción completa

Detalles Bibliográficos
Autores principales: Bratti, Vanessa F, Wilson, Brooke E, Fazelzad, Rouhi, Pabani, Aliyah, Zurn, Shalini J, Johnson, Sonali, Sung, Lillian, Rodin, Danielle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9906175/
https://www.ncbi.nlm.nih.gov/pubmed/36746540
http://dx.doi.org/10.1136/bmjopen-2022-068122
_version_ 1784883949249495040
author Bratti, Vanessa F
Wilson, Brooke E
Fazelzad, Rouhi
Pabani, Aliyah
Zurn, Shalini J
Johnson, Sonali
Sung, Lillian
Rodin, Danielle
author_facet Bratti, Vanessa F
Wilson, Brooke E
Fazelzad, Rouhi
Pabani, Aliyah
Zurn, Shalini J
Johnson, Sonali
Sung, Lillian
Rodin, Danielle
author_sort Bratti, Vanessa F
collection PubMed
description INTRODUCTION: Antimicrobial resistance (AMR) is a growing global public health concern and is becoming a significant challenge in the management of patients with cancer. Due to the immunosuppressive nature of cancer treatment, infection is a common complication and the necessary high usage of antibiotics increases the risk of AMR. Failure to adequately prevent and treat infection in patients with cancer as a result of AMR can increase the morbidity and mortality of the disease. The objective of this scoping review is to understand the relationship between AMR and cancer in order to develop effective antimicrobial stewardship in this patient population and minimise the detrimental effects of AMR on cancer outcomes. METHODS AND ANALYSIS: This scoping review will follow the Arksey and O’Malley methodology framework. An exploratory review of the literature on antibiotic resistance in cancer care will help to define the research questions (stage 1). A broad range of electronic databases (MEDLINE ALL, Cochrane Central Register of Controlled Trials, Cochrane Database of Systematic Reviews and Embase) and search terms will be used to retrieve relevant articles published between 2000 and 2021 (stage 2). Studies will be systematically selected based on the eligibility criteria by two independent reviewers (stage 3). The titles and abstracts will be appraised to determine whether articles meet the eligibility criteria. This will be followed by screening of the full texts and only relevant publications will be retrieved. Data will then be extracted, collated and charted (stage 4); and the summary of aggregated results will be presented (stage 5). ETHICS AND DISSEMINATION: As this scoping review will collect and synthesise data from publicly available sources, no ethics review is required. When data collection and summarisation is completed, results will be disseminated through peer-reviewed publication and the key findings of the review will be presented at relevant conferences.
format Online
Article
Text
id pubmed-9906175
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-99061752023-02-08 Scoping review protocol on the impact of antimicrobial resistance on cancer management and outcomes Bratti, Vanessa F Wilson, Brooke E Fazelzad, Rouhi Pabani, Aliyah Zurn, Shalini J Johnson, Sonali Sung, Lillian Rodin, Danielle BMJ Open Global Health INTRODUCTION: Antimicrobial resistance (AMR) is a growing global public health concern and is becoming a significant challenge in the management of patients with cancer. Due to the immunosuppressive nature of cancer treatment, infection is a common complication and the necessary high usage of antibiotics increases the risk of AMR. Failure to adequately prevent and treat infection in patients with cancer as a result of AMR can increase the morbidity and mortality of the disease. The objective of this scoping review is to understand the relationship between AMR and cancer in order to develop effective antimicrobial stewardship in this patient population and minimise the detrimental effects of AMR on cancer outcomes. METHODS AND ANALYSIS: This scoping review will follow the Arksey and O’Malley methodology framework. An exploratory review of the literature on antibiotic resistance in cancer care will help to define the research questions (stage 1). A broad range of electronic databases (MEDLINE ALL, Cochrane Central Register of Controlled Trials, Cochrane Database of Systematic Reviews and Embase) and search terms will be used to retrieve relevant articles published between 2000 and 2021 (stage 2). Studies will be systematically selected based on the eligibility criteria by two independent reviewers (stage 3). The titles and abstracts will be appraised to determine whether articles meet the eligibility criteria. This will be followed by screening of the full texts and only relevant publications will be retrieved. Data will then be extracted, collated and charted (stage 4); and the summary of aggregated results will be presented (stage 5). ETHICS AND DISSEMINATION: As this scoping review will collect and synthesise data from publicly available sources, no ethics review is required. When data collection and summarisation is completed, results will be disseminated through peer-reviewed publication and the key findings of the review will be presented at relevant conferences. BMJ Publishing Group 2023-02-06 /pmc/articles/PMC9906175/ /pubmed/36746540 http://dx.doi.org/10.1136/bmjopen-2022-068122 Text en © Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Global Health
Bratti, Vanessa F
Wilson, Brooke E
Fazelzad, Rouhi
Pabani, Aliyah
Zurn, Shalini J
Johnson, Sonali
Sung, Lillian
Rodin, Danielle
Scoping review protocol on the impact of antimicrobial resistance on cancer management and outcomes
title Scoping review protocol on the impact of antimicrobial resistance on cancer management and outcomes
title_full Scoping review protocol on the impact of antimicrobial resistance on cancer management and outcomes
title_fullStr Scoping review protocol on the impact of antimicrobial resistance on cancer management and outcomes
title_full_unstemmed Scoping review protocol on the impact of antimicrobial resistance on cancer management and outcomes
title_short Scoping review protocol on the impact of antimicrobial resistance on cancer management and outcomes
title_sort scoping review protocol on the impact of antimicrobial resistance on cancer management and outcomes
topic Global Health
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9906175/
https://www.ncbi.nlm.nih.gov/pubmed/36746540
http://dx.doi.org/10.1136/bmjopen-2022-068122
work_keys_str_mv AT brattivanessaf scopingreviewprotocolontheimpactofantimicrobialresistanceoncancermanagementandoutcomes
AT wilsonbrookee scopingreviewprotocolontheimpactofantimicrobialresistanceoncancermanagementandoutcomes
AT fazelzadrouhi scopingreviewprotocolontheimpactofantimicrobialresistanceoncancermanagementandoutcomes
AT pabanialiyah scopingreviewprotocolontheimpactofantimicrobialresistanceoncancermanagementandoutcomes
AT zurnshalinij scopingreviewprotocolontheimpactofantimicrobialresistanceoncancermanagementandoutcomes
AT johnsonsonali scopingreviewprotocolontheimpactofantimicrobialresistanceoncancermanagementandoutcomes
AT sunglillian scopingreviewprotocolontheimpactofantimicrobialresistanceoncancermanagementandoutcomes
AT rodindanielle scopingreviewprotocolontheimpactofantimicrobialresistanceoncancermanagementandoutcomes